Skin Cancer & Perineural Spread(Squamous Cell Carcinoma)
Addressing complex facial nerve involvement caused by aggressive cutaneous malignancies.
What is Perineural Invasion?
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer. While most cases are successfully treated with minor outpatient procedures (like Mohs micrographic surgery), some aggressive tumors exhibit a behavior known as perineural invasion (PNI).
Perineural invasion occurs when cancer cells identify, attach to, and spread along the pathways of nerves. Because the facial nerve (which controls movement) and the trigeminal nerve (which provides sensation) weave superficially just beneath the skin of the face, they are particularly vulnerable to being hijacked by aggressive skin cancers.
As the tumor tracks along the nerve pathway, it effectively destroys the nerve's ability to transmit electrical signals, leading to profound facial paralysis. Treating these cancers requires extensive oncologic resection (often coordinated with parotid gland surgery) and complex, specialized facial reanimation.
Multidisciplinary Oncologic Care
Facial paralysis resulting from skin cancer requires urgent, multidisciplinary care. If you experience new or worsening facial weakness near a current or previous skin cancer site, it is a significant warning sign of perineural spread.
Cancer control is the first treatment priority. Dr. Jowett works with Mohs surgeons, head and neck oncologists, and radiation oncologists to plan immediate or delayed facial nerve reconstruction according to disease extent and the overall treatment plan.
Skin Cancer Nerve Involvement Signs
Perineural spread can be insidious. Symptoms may develop months or even years after a skin cancer was seemingly removed.
Progressive Weakness
Unlike Bell's Palsy which happens overnight, paralysis from cancer typically worsens slowly over weeks or months, starting in one isolated area (like an eyebrow) and spreading.
Pain or Numbness
Because tumors often invade both motor and sensory nerves, you may experience "formication" (a crawling sensation on the skin), sharp shooting pain, or areas of complete numbness.
Post-Operative Paralysis
If the nerve was directly excised during a Mohs procedure or radical neck dissection to clear the tumor margins, immediate flaccid paralysis will occur on the affected side.
Skin Cancer Facial Reconstruction Options
Reconstruction following aggressive skin cancer is highly individualized and must account for missing skin, underlying tissue, and whether radiation therapy is required.
If the cancer is removed with clear margins and the proximal facial nerve (near the brain) is intact, Dr. Jowett can perform immediate nerve grafting. A sensory nerve from another part of the body is spliced in to bridge the gap created by the tumor resection.
What the Evidence Shows
A slow facial droop after skin cancer is not Bell's palsy until proven otherwise.
- Perineural spread can present as isolated facial weakness with no obvious skin lesion and a delay of many months.
- Red flags include gradual onset, one branch only, no recovery, no synkinesis, and numbness or formication in the trigeminal territory.
- Contrast MRI of the nerve path is the highest-yield study. Skip lesions mean a normal scan does not always close the case.
- Treatment follows high-risk cutaneous squamous-cell principles: surgery when possible, then radiation for named-nerve involvement.
- Care is planned by a team that spans dermatology, head and neck surgery, radiation oncology, radiology, medical oncology, and eye care, with staging scans used to check the lymph nodes and the rest of the body.
- The surgical goal is a clear margin at the deep end of the nerve, to stop disease advancing toward the skull base. Whether an operation is possible depends on how far along the nerve the cancer has already travelled.
- Results are less favorable when disease reaches closer to the skull base, when lymph nodes are involved, or when margins are not clear. Cure is possible but cannot be promised.
- PD-1 immunotherapy such as cemiplimab is approved for advanced cutaneous squamous-cell carcinoma that surgery and radiation cannot cure, and is being studied before surgery. Its exact role in perineural disease is still being defined.
- Most recurrences appear within the first two years. Visits every three to six months early on, lifelong skin and lymph node checks, and prompt reporting of new facial weakness, numbness, or pain are part of the plan.
Why Choose Revitalis for Skin Cancer Reconstruction?
Dr. Nate Jowett is a facial nerve surgeon whose clinical and peer-reviewed work includes facial reanimation. His fellowship training and background span facial plastic surgery, engineering, and reconstructive microsurgery.
Whether you are days into a diagnosis or have lived with incomplete recovery for years, Dr. Jowett offers the full spectrum of care, from medical management to cutting-edge surgical reconstruction, to help you regain your smile and confidence.
Common questions
Questions Patients Ask
What symptoms suggest perineural spread?
Progressive or branch-specific facial weakness, persistent facial pain, numbness, tingling, twitching, reduced corneal sensation, or new cranial nerve symptoms are concerning—especially after skin cancer of the face, scalp, ear, or temple.
Can perineural spread be missed on an ordinary MRI?
Yes. Imaging should be tailored to the suspected nerve pathway and skull base, typically with contrast and thin sections. The clinical question should be communicated directly to an experienced head-and-neck radiology team.
Can facial reconstruction happen during cancer care?
Often it can be planned alongside tumor surgery or staged around radiation and systemic treatment. Immediate priorities include complete cancer management and corneal protection, followed by nerve, eyelid, and smile reconstruction appropriate to the defect.
How long after a skin cancer is removed can perineural spread appear?
It can appear months or even years after the original skin lesion was treated, which is why a slowly progressive facial droop in someone with a history of skin cancer deserves prompt specialist evaluation rather than a diagnosis of Bell's palsy.
Do I need both surgery and radiation?
Often, yes. The established backbone of curative treatment is surgery aimed at a clear margin at the deep end of the nerve, followed by radiation directed at the nerve pathway. Radiation is sometimes the main treatment when surgery is not possible or would not be curative.
Is immunotherapy an option?
PD-1 immunotherapy such as cemiplimab is approved for advanced cutaneous squamous-cell carcinoma that surgery and radiation cannot cure, and it is being studied before surgery to shrink tumors. Its exact role and timing in perineural disease are still being defined, so it is an individualized discussion with the oncology team.
How often will I need follow-up after treatment?
Most recurrences appear within the first two years, so visits every three to six months in the early years are typical, spacing out afterward but continuing for life. Your own reported symptoms are one of the most reliable signals, so new facial weakness, numbness, or pain should be reported right away.
Answers are general and individualized at consultation.
Medical References & Evidence-Based Guidelines
- Persisting Facial Nerve Palsy or Trigeminal Neuralgia - Red Flags for Perineural Spread of Head and Neck Cutaneous Squamous Cell Carcinoma. Zhang M, Phung D, Gupta R, et al. ANZ J Surg. 2023;93(10):2430-2435. PMID: 37485776.
- A General Approach to Facial Palsy. Jowett N. A General Approach to Facial Palsy. Otolaryngol Clin North Am. 2018 Dec; 51(6):1019-1031. PMID: 30119926.
- A Contemporary Approach to Facial Reanimation. Jowett N, Hadlock TA. JAMA Facial Plast Surg. 2015 Jul-Aug; 17(4):293-300. PMID: 26042960.
- Clinical Practice Guideline: Bell's Palsy. Baugh RF, Basura GJ, Ishii LE, et al. Otolaryngol Head Neck Surg. 2013;149(3 Suppl):S1-S27. PMID: 24133746.
- Use of Imaging in Cutaneous Squamous Cell Carcinoma to Detect High-Risk Tumor Features, Nodal Metastasis, and Distant Metastasis: A Systematic Review. Libson K, Sheridan C, Carr DR, et al. Dermatol Surg. 2024;50(8):705-709. PMID: 38624106.
- Immunotherapy and Radiation for Clinical Perineural Invasion in Cutaneous Squamous Cell Carcinoma. Morecroft RA, Phillipps JS, Gou L, et al. Cancers (Basel). 2025;17(24). PMID: 41463172.
- A Multi-Institutional Review of Characteristics of Idiopathic Versus Non-Idiopathic Facial Paralysis. Mandava S, Gossett K, Monaghan NP, et al. Laryngoscope. 2025;135(8):2882-2888. PMID: 40088138.